The search for novel antipsychotics: pharmacological and molecular targets.
about
How antipsychotics work-from receptors to reality.F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics.Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism.Antipsychotic-Like Efficacy of Dopamine D2 Receptor-Biased Ligands is Dependent on Adenosine A2A Receptor Expression.
P2860
The search for novel antipsychotics: pharmacological and molecular targets.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The search for novel antipsychotics: pharmacological and molecular targets.
@ast
The search for novel antipsychotics: pharmacological and molecular targets.
@en
type
label
The search for novel antipsychotics: pharmacological and molecular targets.
@ast
The search for novel antipsychotics: pharmacological and molecular targets.
@en
prefLabel
The search for novel antipsychotics: pharmacological and molecular targets.
@ast
The search for novel antipsychotics: pharmacological and molecular targets.
@en
P2860
P356
P1476
The search for novel antipsychotics: pharmacological and molecular targets.
@en
P2093
David J Sanger
P2860
P304
P356
10.1517/14728222.8.6.631
P407
P577
2004-12-01T00:00:00Z